Detection of Epidemic Scarlet Fever Group A Streptococcus in Australia.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
13 09 2019
Historique:
received: 19 10 2018
accepted: 30 01 2019
pubmed: 6 2 2019
medline: 10 9 2020
entrez: 6 2 2019
Statut: ppublish

Résumé

Sentinel hospital surveillance was instituted in Australia to detect the presence of pandemic group A Streptococcus strains causing scarlet fever. Genomic and phylogenetic analyses indicated the presence of an Australian GAS emm12 scarlet fever isolate related to United Kingdom outbreak strains. National surveillance to monitor this pandemic is recommended.

Identifiants

pubmed: 30721938
pii: 5306630
doi: 10.1093/cid/ciz099
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1232-1234

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Mark J Walker (MJ)

Australian Infectious Diseases Research Centre, University of Queensland, Brisbane.

Stephan Brouwer (S)

Australian Infectious Diseases Research Centre, University of Queensland, Brisbane.

Brian M Forde (BM)

Australian Infectious Diseases Research Centre, University of Queensland, Brisbane.

Kate A Worthing (KA)

Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.

Liam McIntyre (L)

Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.

Lana Sundac (L)

Pathology Queensland, Gold Coast Laboratory, Brisbane, Australia.

Sam Maloney (S)

Pathology Queensland, Gold Coast Laboratory, Brisbane, Australia.

Leah W Roberts (LW)

Australian Infectious Diseases Research Centre, University of Queensland, Brisbane.

Timothy C Barnett (TC)

Australian Infectious Diseases Research Centre, University of Queensland, Brisbane.

Johanna Richter (J)

Australian Infectious Diseases Research Centre, University of Queensland, Brisbane.

Amanda J Cork (AJ)

Australian Infectious Diseases Research Centre, University of Queensland, Brisbane.

Adam D Irwin (AD)

University of Queensland Centre for Clinical Research, Brisbane, Australia.
Queensland Children's Hospital, Brisbane, Australia.

Yuanhai You (Y)

State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation, Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.

Jianzhong Zhang (J)

State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation, Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing.

Gordon Dougan (G)

Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.

Kwok Y Yuen (KY)

Department of Microbiology, University of Hong Kong, Hong Kong Special Administrative Region, China.
Research Centre of Infection and Immunology, University of Hong Kong, Hong Kong Special Administrative Region, China.
State Key Laboratory for Emerging Infectious Diseases, University of Hong Kong, Hong Kong Special Administrative Region, China.

Victor Nizet (V)

Division of Host-Microbe Systems and Therapeutics, Department of Pediatrics, University of California, San Diego, La Jolla.

Scott A Beatson (SA)

Australian Infectious Diseases Research Centre, University of Queensland, Brisbane.

Keith Grimwood (K)

Menzies Health Institute Queensland, Griffith University, Gold Coast.
Departments of Infectious Diseases and Pediatrics, Gold Coast Health, Queensland, Australia.

Mark R Davies (MR)

Department of Microbiology and Immunology, University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH